Korlym

Active Ingredient(s): Mifepristone
FDA Approved: * February 17, 2012
Pharm Company: * CORCEPT THERAPEUTICS
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Korlym Overview

Mifepristone (or RU-486) is a synthetic, steroidal antiprogestogen and antiglucocorticoid pharmaceutical drug. It is a 19-norsteroid with substitutions at positions C11 and C17 (17β-hydroxy-11β-(4-(dimethylamino)phenyl)-17α-(1-propynyl)estra-4,9-dien-3-one), which antagonizes cortisol action competitively at the receptor level.[1] Mifepristone is a low-efficacy partial agonist of the progesterone receptor used as an abortifacient in the first months of pregnancy, and in smaller...

Read more Korlym Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mifepristone

Recent Korlym Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mifepristone
  • Tablet: 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Korlym: (1 result)

Sorted by National Drug Code
  • 76346-073 Korlym 300 mg Oral Tablet by Corcept Therapeutics Inc

Other drugs which contain Mifepristone or a similar ingredient: (2 results)